Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2

OBJECTIVES: To identify the most efficacious timing for tocilizumab administration in critically ill patients infected with severe acute respiratory syndrome coronavirus-2. DESIGN: Observational multicenter cohort study. SETTING: A total of 23 acute care hospitals in four states. PATIENTS: One-hundr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Crit Care Explor
Main Authors: Petrak, Russell M., Van Hise, Nicholas W., Skorodin, Nathan C., Fliegelman, Robert M., Chundi, Vishnu, Didwania, Vishal, Han, Alice, Harting, Brian P., Hines, David W.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
Original Clinical Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8009634/
https://ncbi.nlm.nih.gov/pubmed/33817660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCE.0000000000000395
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados